Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | EGFR | P00533 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25846222 | 0.87 | CYP1A2 (0.62) | CYP3A4CYP1A2BLMKDM4EALDH1A1 | |
| SCHEMBL25846204 | 0.81 | SLC6A2 (0.47) | CYP3A4CYP1A2BLMKDM4EALDH1A1 | |
| SCHEMBL25751730 | 0.77 | ESR1 (0.48) | CYP3A4CYP1A2BLMKDM4EALDH1A1 | |
| SCHEMBL13431276 | 0.77 | KDM4E (0.76) | CYP3A4CYP1A2BLMKDM4EALDH1A1 | |
| SCHEMBL25846202 | 0.77 | KDM4E (0.76) | CYP3A4CYP1A2BLMKDM4EALDH1A1 | |
| SCHEMBL25846208 | 0.74 | ESR1 (0.35) | CYP3A4CYP1A2BLMKDM4EALDH1A1 | |
| SCHEMBL25846223 | 0.74 | ESR1 (0.35) | CYP3A4CYP1A2BLMKDM4EALDH1A1 | |
| SCHEMBL16263574 | 0.74 | BLM (0.73) | CYP3A4CYP1A2BLMKDM4EALDH1A1 | |
| SCHEMBL3872299 | 0.72 | ALDH1A1 (0.64) | CYP3A4CYP1A2BLMKDM4EALDH1A1 | |
| SCHEMBL25596139 | 0.72 | BLM (0.47) | CYP3A4CYP1A2BLMKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11702383-B2 | Methods for producing D-α-methyldopa | IMMUNOMOLECULAR THERAPEUTICS, INC. (US) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702383-B2 | Methods for producing D-α-methyldopa | AMPD2, AMPD3, AMPD1 | CYP3A4 365/4885CYP1A2 330/4885BLM 4024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.